Marcia Cruz-Correa to Barrett Esophagus
This is a "connection" page, showing publications Marcia Cruz-Correa has written about Barrett Esophagus.
Connection Strength
0.399
-
Magno P, Gonz?lez L, Cruz-Correa M, Su?rez E. The prevalence of Barrett's-esophagus-associated dysplasia in Puerto Rico. P R Health Sci J. 2014 Dec; 33(4):184-9.
Score: 0.123
-
Chak A, Buttar NS, Foster NR, Seisler DK, Marcon NE, Schoen R, Cruz-Correa MR, Falk GW, Sharma P, Hur C, Katzka DA, Rodriguez LM, Richmond E, Sharma AN, Smyrk TC, Mandrekar SJ, Limburg PJ. Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2015 Apr; 13(4):665-72.e1-4.
Score: 0.121
-
Falk GW, Buttar NS, Foster NR, Ziegler KL, Demars CJ, Romero Y, Marcon NE, Schnell T, Corley DA, Sharma P, Cruz-Correa MR, Hur C, Fleischer DE, Chak A, Devault KR, Weinberg DS, Della'Zanna G, Richmond E, Smyrk TC, Mandrekar SJ, Limburg PJ. A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. Gastroenterology. 2012 Oct; 143(4):917-26.e1.
Score: 0.104
-
Gross CP, Cruz-Correa M, Canto MI, McNeil-Solis C, Valente TW, Powe NR. The adoption of ablation therapy for Barrett's esophagus: a cohort study of gastroenterologists. Am J Gastroenterol. 2002 Feb; 97(2):279-86.
Score: 0.051